CareRay Digital Medical Technology Co., Ltd. (SHA:688607)
35.26
-2.06 (-5.52%)
Nov 13, 2026, 3:00 PM CST
SHA:688607 Revenue
CareRay Digital Medical Technology had revenue of 84.14M CNY in the quarter ending September 30, 2026, with 3.70% growth. This brings the company's total for the last twelve months to 322.80M, down -1.77% year-over-year. In the year 2025, CareRay Digital Medical Technology had annual revenue of 320.86M with 7.63% growth. That makes CareRay Digital Medical Technology the 28,221st largest company in the world by revenue and 4,834th in China.
Revenue (ttm)
322.80M
Revenue Growth
-1.77%
P/S Ratio
9.55
Revenue / Employee
1.10M
Employees
294
Market Cap
3.08B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:688607 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 320.86M | 22.76M | 7.63% |
| Dec 31, 2024 | 298.10M | 24.36M | 8.90% |
| Dec 31, 2023 | 273.74M | 69.17M | 33.81% |
| Dec 31, 2022 | 204.57M | -137.41M | -40.18% |
| Dec 31, 2021 | 341.98M | 2.76M | 0.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.12B |
| Guangdong Transtek Medical Electronics | 1.05B |
| Zhejiang Orient Gene Biotech | 993.10M |
| Jiangsu Hanbon Science and Technology | 849.02M |
| Beijing Leadman Biochemistry | 485.94M |
| Chison Medical Technologies | 443.67M |
| Medprin Regenerative Medical Technologies | 413.92M |
| Shanghai General Healthy Information and Technology | 350.19M |